Launched in April 2022, Cellistic specializes in process development and manufacture of cell therapies based on human induced pluripotent stem cell (iPSC) technology. The company’s focus and expertise in iPSC generation and differentiation protocol development makes it well-positioned to partner with innovative cell therapy developers to establish novel advanced therapies. With more than a decade of scientific and technical knowledge transfer from sister company Ncardia, Cellistic is uniquely experienced in designing and optimizing manufacturing procedures for iPSCs that deliver quality products at scale. 

For more information, visit www.cellistic.com. 


Biotechnology

Life Sciences

Therapeutics

Cellistic

Cellistic's headquarters in Mont-Saint-Guibert, Belgium

This department conducts scientific research and develops methodologies to advance product innovation and quality.

Research and Development

This department is responsible for ensuring that products and services meet established quality standards through testing and evaluation.

Quality Assurance

This department manages and supports the organization's technology infrastructure and services.

Information Technology

The Leadership Team at Cellistic is responsible for setting the strategic direction, overseeing the implementation of key initiatives, and ensuring operational excellence across the company. This team drives the growth and innovation in the manufacturing of cell therapies by leveraging their deep expertise in iPSC technology and working collaboratively to maintain the company's competitive edge. Key decisions regarding technical advancements, commercial strategies, financial planning, and cell line development are steered by this group to continually align with the company's mission and industry standards.

Leadership Team

This department is responsible for overseeing and managing the production process, ensuring efficiency and quality in the production of goods.

Production Operations

The Scientific and Engineering team at Cellistic is responsible for the development, optimization, and scaling of manufacturing processes for human induced pluripotent stem cell (iPSC) therapies. This multidisciplinary team combines expertise in process engineering, bioprocessing, and analytical development to ensure the production of high-quality cell therapy products. Their work includes designing differentiation protocols, optimizing bioprocesses, and ensuring rigorous analytical testing to meet regulatory standards.

People (11)

Jobs (0)

Other teams

Quality Assurance

Information Technology

Leadership Team

Production Operations

Scientific and Engineering